Profile for South Korea Patent: 20190108592
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 20190108592
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,969,544 | Feb 20, 2040 | Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate |
| 11,969,544 | Feb 20, 2040 | Teva Pharm | AIRDUO RESPICLICK | fluticasone propionate; salmeterol xinafoate |
| 11,969,544 | Feb 20, 2040 | Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate |
| 11,969,544 | Feb 20, 2040 | Teva Pharm | ARMONAIR RESPICLICK | fluticasone propionate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
